Short-term effect of the addition of leukotriene receptor antagonists to the current therapy in severe asthmatics

Pulmonary Pharmacology and Therapeutics

Volumn 16, Issue 4, 2003, Pages 237-240

  Tonelli, M ^a   Zingoni, M ^a   Bacci, E ^a   Dente, F L ^a   Di Franco, A ^a   Giannini, D ^a   Taccola, M ^a   Vagaggini, B ^a   Paggiaro, P L ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Asthma; Leukotrienes; Montelukast; Zafirlukast

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; ZAFIRLUKAST;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SCREENING; DRUG SENSITIVITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; SYMPTOM;

EID: 0038693136     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1094-5539(03)00054-3     Document Type: Article

References (17)

1. Difficult/therapy-resistant asthma. Eur Respir J. 13:1999;1198-1208.
2. Smith D.H., Malone D.C., Lawson K.A., Okamoto L.J., Battista C., Saunders W.B. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med. 156:1997;787-793.
3. Spector S.L., Smith L.J., Glass M., The Accolate Asthma Trialists Group. Effects of 6 weeks of therapy with oral dose of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. Am J Respir Crit Care Med. 150:1994;618-623.
4. Laviolette M., Malmstrom K., Lu S., Chervinsky P., Pujet J.C., Peszek I., Zhang J., Reiss T.F., The Montelukast/Beclomethasone Additivity Group. Montelukast added to inhaled beclomethasone in treatment of asthma. Am J Respir Crit Care Med. 160:1999;1862-1868.
5. Kohrogi H., Iwagoe H., Fujii K., Hamamoto J., Fukuda K., Hirata N., Kawano O., Matsumoto M., Suga M., Ando M. The role of cysteinyl leukotrienes in the pathogenesis of asthma: clinical study of leukotriene antagonist pranlukast for 1 year in moderate and severe asthma. Respirology. 4:1999;319-323.
6. Kemp J.P., Minkwitz M.C., Bonuccelli C.M., Warren M.S. Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma. Chest. 115:1999;336-342.
7. Virchow J.C., Prasse A., Naya I., Sumlmerton L., Harris A., The Zafirlukast Study Group. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med. 162:2000;578-585.
8. Global Initiative for Asthma. NIH Publication No. 95-3659, January 1995.
9. Standardization of spirometry: 1987 update. Am Rev Respir Dis. 136:1987;1285-1298.
10. Santanello N.C., Zhang J., Seidenberg B., Reiss T.F., Barber B.L. What are minimal important changes for asthma measures in a clinical trial? Eur Respir J. 14:1999;23-27.
11. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., Yernault J.C. Standardization of lung function tests for the European Community for steel and coal. Official statement of the European Respiratory Society. Eur Respir J. 6:(Suppl. 16):1993;5-40.
12. Hui K.P., Barnes N.C. Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist. Lancet. 337:1991;1062-1063.
13. Dockhorn R.J., Baumgartner R.A., Leff J.A., Noonan M., Vandormael K., Stricker W., Weinland D.E., Reiss T.F. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax. 55:2000;260-265.
14. Robinson D.S., Campbell D., Barnes P.J. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial. Lancet. 357:2001;2007-2011.
15. Tohda Y., Fujimura M., Taniguchi H., Takagi K., Igarashi T., Yasuhara H., Takahasi K., Nakajima S. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients. Clin Exper Allergy. 32:2002;1180-1186.
16. Lane S.J. Leukotriene antagonism in asthma and rhinitis. Respir Med. 92:1998;795-809.
17. Smith C.M., Hawksworth R.J., Thien F.C.K., Christie P.E., Lee T.H. Urinary leukotriene E4 in bronchial asthma. Eur Respir J. 5:1992;693-699.